A randomized, double-blinded, placebo-controlled trial to investigate viral shedding in healthy children (6 mos and less than or equal to 18 months of age) vaccinated with two doses of liquid formulation of influenza virus vaccine, live cold adapted (CAIV-T)

Trial Profile

A randomized, double-blinded, placebo-controlled trial to investigate viral shedding in healthy children (6 mos and less than or equal to 18 months of age) vaccinated with two doses of liquid formulation of influenza virus vaccine, live cold adapted (CAIV-T)

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2006

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors MedImmune
  • Most Recent Events

    • 27 Dec 2006 Status change
    • 09 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top